The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery

Fabian Grass, Signe Braafladt, Jasim Alabbad, Jenna K. Lovely, Scott R. Kelley, Kellie L. Mathis, Marianne Huebner, David Larson

Research output: Contribution to journalArticle

Abstract

Background: The present study aimed to evaluate safety of tranexamic acid (TA) administration and to assess bleeding risk in colorectal surgery (CRS). Methods: Retrospective cohort study including consecutive patients undergoing elective CRS by a single surgeon between August 2014 and May 2015. All patients received 1 g of TA intravenously at induction and at closure. Demographics, operative and postoperative details were prospectively assessed and compared to a historical control cohort. Results: 213 patients were evaluated. TA did not increase complications, readmissions, or reoperation rates. Significant postoperative hemoglobin (Hgb) drop (≥3 g/dL) (TA: n = 6, 7.4%, Control: n = 22, 16.6%; p = 0.193) and transfusion rates (intraoperative: TA: n = 2, 2.5%, Control: n = 2, 1.5%; p = 0.586, postoperative: TA: n = 1, 1.2%, Control: 9, 6.8%; p = 0.065) were not statistically different. Conclusions: Postoperative hemoglobin drop and transfusion rates were not decreased statistically. Further study is warranted given the large clinical differences in favor of TA. Tranexamic acid (TA) administration did not increase complications, readmissions or reoperations in this consecutive, unselected cohort of colorectal surgical patients. Postoperative hemoglobin drop and transfusion rate were not decreased statistically; however, large clinical differences in favor of TA warrant further study.

Original languageEnglish (US)
JournalAmerican journal of surgery
DOIs
StatePublished - Jan 1 2019

Fingerprint

Tranexamic Acid
Colorectal Surgery
Blood Transfusion
Hemoglobins
Reoperation
Cohort Studies
Retrospective Studies
Demography
Hemorrhage
Safety

Keywords

  • Colorectal surgery
  • Patient outcomes
  • Tranexamic acid

ASJC Scopus subject areas

  • Surgery

Cite this

The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery. / Grass, Fabian; Braafladt, Signe; Alabbad, Jasim; Lovely, Jenna K.; Kelley, Scott R.; Mathis, Kellie L.; Huebner, Marianne; Larson, David.

In: American journal of surgery, 01.01.2019.

Research output: Contribution to journalArticle

Grass, Fabian ; Braafladt, Signe ; Alabbad, Jasim ; Lovely, Jenna K. ; Kelley, Scott R. ; Mathis, Kellie L. ; Huebner, Marianne ; Larson, David. / The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery. In: American journal of surgery. 2019.
@article{f4d84790791a4295ac1709b1779e99d0,
title = "The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery",
abstract = "Background: The present study aimed to evaluate safety of tranexamic acid (TA) administration and to assess bleeding risk in colorectal surgery (CRS). Methods: Retrospective cohort study including consecutive patients undergoing elective CRS by a single surgeon between August 2014 and May 2015. All patients received 1 g of TA intravenously at induction and at closure. Demographics, operative and postoperative details were prospectively assessed and compared to a historical control cohort. Results: 213 patients were evaluated. TA did not increase complications, readmissions, or reoperation rates. Significant postoperative hemoglobin (Hgb) drop (≥3 g/dL) (TA: n = 6, 7.4{\%}, Control: n = 22, 16.6{\%}; p = 0.193) and transfusion rates (intraoperative: TA: n = 2, 2.5{\%}, Control: n = 2, 1.5{\%}; p = 0.586, postoperative: TA: n = 1, 1.2{\%}, Control: 9, 6.8{\%}; p = 0.065) were not statistically different. Conclusions: Postoperative hemoglobin drop and transfusion rates were not decreased statistically. Further study is warranted given the large clinical differences in favor of TA. Tranexamic acid (TA) administration did not increase complications, readmissions or reoperations in this consecutive, unselected cohort of colorectal surgical patients. Postoperative hemoglobin drop and transfusion rate were not decreased statistically; however, large clinical differences in favor of TA warrant further study.",
keywords = "Colorectal surgery, Patient outcomes, Tranexamic acid",
author = "Fabian Grass and Signe Braafladt and Jasim Alabbad and Lovely, {Jenna K.} and Kelley, {Scott R.} and Mathis, {Kellie L.} and Marianne Huebner and David Larson",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.amjsurg.2019.03.013",
language = "English (US)",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery

AU - Grass, Fabian

AU - Braafladt, Signe

AU - Alabbad, Jasim

AU - Lovely, Jenna K.

AU - Kelley, Scott R.

AU - Mathis, Kellie L.

AU - Huebner, Marianne

AU - Larson, David

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: The present study aimed to evaluate safety of tranexamic acid (TA) administration and to assess bleeding risk in colorectal surgery (CRS). Methods: Retrospective cohort study including consecutive patients undergoing elective CRS by a single surgeon between August 2014 and May 2015. All patients received 1 g of TA intravenously at induction and at closure. Demographics, operative and postoperative details were prospectively assessed and compared to a historical control cohort. Results: 213 patients were evaluated. TA did not increase complications, readmissions, or reoperation rates. Significant postoperative hemoglobin (Hgb) drop (≥3 g/dL) (TA: n = 6, 7.4%, Control: n = 22, 16.6%; p = 0.193) and transfusion rates (intraoperative: TA: n = 2, 2.5%, Control: n = 2, 1.5%; p = 0.586, postoperative: TA: n = 1, 1.2%, Control: 9, 6.8%; p = 0.065) were not statistically different. Conclusions: Postoperative hemoglobin drop and transfusion rates were not decreased statistically. Further study is warranted given the large clinical differences in favor of TA. Tranexamic acid (TA) administration did not increase complications, readmissions or reoperations in this consecutive, unselected cohort of colorectal surgical patients. Postoperative hemoglobin drop and transfusion rate were not decreased statistically; however, large clinical differences in favor of TA warrant further study.

AB - Background: The present study aimed to evaluate safety of tranexamic acid (TA) administration and to assess bleeding risk in colorectal surgery (CRS). Methods: Retrospective cohort study including consecutive patients undergoing elective CRS by a single surgeon between August 2014 and May 2015. All patients received 1 g of TA intravenously at induction and at closure. Demographics, operative and postoperative details were prospectively assessed and compared to a historical control cohort. Results: 213 patients were evaluated. TA did not increase complications, readmissions, or reoperation rates. Significant postoperative hemoglobin (Hgb) drop (≥3 g/dL) (TA: n = 6, 7.4%, Control: n = 22, 16.6%; p = 0.193) and transfusion rates (intraoperative: TA: n = 2, 2.5%, Control: n = 2, 1.5%; p = 0.586, postoperative: TA: n = 1, 1.2%, Control: 9, 6.8%; p = 0.065) were not statistically different. Conclusions: Postoperative hemoglobin drop and transfusion rates were not decreased statistically. Further study is warranted given the large clinical differences in favor of TA. Tranexamic acid (TA) administration did not increase complications, readmissions or reoperations in this consecutive, unselected cohort of colorectal surgical patients. Postoperative hemoglobin drop and transfusion rate were not decreased statistically; however, large clinical differences in favor of TA warrant further study.

KW - Colorectal surgery

KW - Patient outcomes

KW - Tranexamic acid

UR - http://www.scopus.com/inward/record.url?scp=85063276722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063276722&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2019.03.013

DO - 10.1016/j.amjsurg.2019.03.013

M3 - Article

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

ER -